Dr. Smeets financials
A multi-period view of the public annual-account figures reported for Dr. Smeets, with comparable measures and links to available source documents.
Company overviewRegistry number
1013606646
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for Dr. Smeets
2025 versus 2024
- Operating line
- €56,016
- EBITDA
- €55,257
- Total assets
- €110,249
- Equity
- €68,239
+85.1%
+85.2%
+192.4%
+164.5%
EBITDA margin +98.6% · Equity ratio +61.9%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €56,016 | €55,257 | €110,249 | €68,239 | - |
| 202431 Dec 2024 | €30,269 | €29,839 | €37,706 | €25,802 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.